5-Chloro-2-(chloromethyl)pyridine hydrochloride, 95.0%, 250mg

(S)-3-(5-bromo-1H-indol-3-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 98%, 1g

3-chloro-1-methylpyrazin-2(1H)-one, 95.0%, 250mg

1-(2,2,2-Trifluoro-ethyl)-1 H -pyrazol-4-ylamine, 95.0%, 250mg

(3R)-4-(4-Fluorobenzoyl)-3-methyl-2-piperazinone, 97%, 100mg

2-Bromoethyl Acetate>98.0%(GC)500g

N-tert-Butylmethacrylamide (stabilized with MEHQ)>97.0%(GC)(T)25g

GC capillary column ROTI®Cap-FFAP, 50 m, 0.32 mm, 0.50 µm, 1 Piece(s)

1,4-Dibromo-2-nitrobenzene>98.0%(GC)250g

2,6-Dimethoxypyridin-3-ylboronic acid, 95.0%, 25g

Thiomorpholine-3-carboxylic acid ethyl ester hydrochloride, 97.0%, 250mg

(11bR)-4-Hydroxy-2,6-bis[4-(2-naphthalenyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 97%, 250mg

3-azidopropan-1-ol, 96%, 1g